Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDDate | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
09/29/2024 | Q2 2024 | -$0.31 | $4.48 M | |||
08/09/2024 | Q1 2024 | $0.13 | $55.13 M | |||
05/30/2024 | Q4 2023 | -$0.19 | $28.93 M | |||
02/13/2024 | Q3 2023 | $6.37 | $37.14 M | |||
11/13/2023 | Q2 2023 | -$0.40 | $37.10 M | |||
08/14/2023 | Q1 2023 | -$0.38 | $21.62 M | |||
06/28/2023 | Q4 2022 | -$0.05 | $27.38 M | |||
02/13/2023 | Q3 2022 | -$0.49 | $17.05 M |
Roivant Sciences Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, December 30th, 2022 based off last year's report dates.
The conference call for Roivant Sciences Ltd.'s latest earnings report can be listened to online.
The conference call transcript for Roivant Sciences Ltd.'s latest earnings report can be read online.
Roivant Sciences Ltd. (:ROIVW) has a recorded annual revenue of $124.80 M.
Roivant Sciences Ltd. (:ROIVW) has a recorded net income of $124.80 M. Roivant Sciences Ltd. has generated $5.55 earnings per share over the last four quarters.
Roivant Sciences Ltd. (:ROIVW) has a price-to-earnings ratio of 1.77 and price/earnings-to-growth ratio is 1.16.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED